论文部分内容阅读
目的分析改良强化胰岛素对神经内科危重症患者的影响。方法选取2012年2月—2015年10月新乡市中心医院神经内科接诊的100例危重症患者,根据治疗方法不同将患者分为观察组和对照组,各50例。观察组采用改良强化胰岛素治疗,对照组采用常规胰岛素治疗,比较两组患者住院时间、清蛋白下降比、感染率、病死率、胰岛素用量、治疗时间、低血糖发生率。结果观察组清蛋白下降高于对照组,胰岛素用量少于对照组,治疗时间短于对照组,感染率、病死率、低血糖发生率低于对照组,差异有统计学意义(P<0.05)。结论采用改良强化胰岛素治疗神经内科危重症患者,可降低患者感染率和病死率,对患者良好预后具有积极影响。
Objective To analyze the effect of modified fortified insulin on the critical patients in neurology. Methods From January 2012 to October 2015, 100 critically ill patients admitted to Department of Neurology, Xinxiang Central Hospital were divided into observation group and control group according to different treatment methods, 50 cases in each group. The observation group was treated with modified intensive insulin. The control group was treated with conventional insulin. The hospital stay, albumin ratio, infection rate, fatality rate, insulin dosage, treatment time and incidence of hypoglycemia were compared between the two groups. Results The decrease of albumin in the observation group was higher than that of the control group, the dosage of insulin was less than that of the control group, and the treatment time was shorter than that of the control group. The infection rate, mortality and incidence of hypoglycemia were lower than those of the control group (P <0.05 ). Conclusions The use of modified and enhanced insulin in the treatment of critically ill neurological patients can reduce the infection rate and mortality, which has a positive effect on the patients’ good prognosis.